Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 68

1.

Latanoprost with high precision, piezo-print microdose delivery for IOP lowering: clinical results of the PG21 study of 0.4 µg daily microdose.

Pasquale LR, Lin S, Weinreb RN, Tsai JC, Kramm RL, Ianchulev T.

Clin Ophthalmol. 2018 Nov 28;12:2451-2457. doi: 10.2147/OPTH.S185027. eCollection 2018.

2.

High-precision piezo-ejection ocular microdosing: Phase II study on local and systemic effects of topical phenylephrine.

Ianchulev T, Weinreb R, Tsai JC, Lin S, Pasquale LR.

Ther Deliv. 2018 Jan;9(1):17-27. doi: 10.4155/tde-2017-0095. Epub 2017 Oct 27.

3.

Latanoprost : an update of its use in glaucoma and ocular hypertension.

Perry CM, McGavin JK, Culy CR, Ibbotson T.

Drugs Aging. 2003;20(8):597-630. Review.

PMID:
12795627
4.

Pharmacodynamic profile of mydriatic agents delivered by ocular piezo-ejection microdosing compared with conventional eyedropper.

Ianchulev T, Chayet A, Kahook M, Packer M, Pasquale L, Weinreb RN.

Ther Deliv. 2016 Nov;7(11):751-760. Epub 2016 Oct 13.

PMID:
27733098
5.
6.

Efficacy and safety of benzalkonium chloride-free fixed-dose combination of latanoprost and timolol in patients with open-angle glaucoma or ocular hypertension.

Bhagat P, Sodimalla K, Paul C, Pandav SS, Raman GV, Ramakrishnan R, Joshi A, Raut A.

Clin Ophthalmol. 2014 Jun 28;8:1241-52. doi: 10.2147/OPTH.S64584. eCollection 2014.

7.

Switching from latanoprost to fixed-combination latanoprost-timolol: a 21-day, randomized, double-masked, active-control study in patients with glaucoma and ocular hypertension.

Olander K, Zimmerman TJ, Downes N, Schoenfelder J; Xalacom/Latanoprost Study Group.

Clin Ther. 2004 Oct;26(10):1619-29.

PMID:
15598478
9.

Latanoprost-Eluting Contact Lenses in Glaucomatous Monkeys.

Ciolino JB, Ross AE, Tulsan R, Watts AC, Wang RF, Zurakowski D, Serle JB, Kohane DS.

Ophthalmology. 2016 Oct;123(10):2085-92. doi: 10.1016/j.ophtha.2016.06.038. Epub 2016 Aug 29.

PMID:
27586444
10.

Fixed-combination brimonidine-timolol versus latanoprost in glaucoma and ocular hypertension: a 12-week, randomized, comparison study.

Katz LJ, Rauchman SH, Cottingham AJ Jr, Simmons ST, Williams JM, Schiffman RM, Hollander DA.

Curr Med Res Opin. 2012 May;28(5):781-8. doi: 10.1185/03007995.2012.681036. Epub 2012 Apr 25.

PMID:
22458918
11.

First-line latanoprost therapy in ocular hypertension or open-angle glaucoma patients: a 3-month efficacy analysis stratified by initial intraocular pressure.

Denis P, Baudouin C, Bron A, Nordmann JP, Renard JP, Rouland JF, Sellem E, Amrane M.

BMC Ophthalmol. 2010 Feb 24;10:4. doi: 10.1186/1471-2415-10-4.

12.

[A challenge to primary open-angle glaucoma including normal-pressure. Clinical problems and their scientific solution].

Sugiyama K.

Nippon Ganka Gakkai Zasshi. 2012 Mar;116(3):233-67; discussion 268. Review. Japanese.

PMID:
22568103
13.

Fixed combination of latanoprost and timolol vs individual components for primary open-angle glaucoma or ocular hypertension: a randomized, double-masked study.

Higginbotham EJ, Olander KW, Kim EE, Grunden JW, Kwok KK, Tressler CS; United States Fixed-Combination Study Group.

Arch Ophthalmol. 2010 Feb;128(2):165-72. doi: 10.1001/archophthalmol.2009.384.

PMID:
20142538
14.

A 12-month, randomized, double-masked study comparing latanoprost with timolol in pigmentary glaucoma.

Mastropasqua L, Carpineto P, Ciancaglini M, Gallenga PE.

Ophthalmology. 1999 Mar;106(3):550-5.

PMID:
10080213
16.

A comparative study of a preservative-free latanoprost cationic emulsion (Catioprost) and a BAK-preserved latanoprost solution in animal models.

Daull P, Buggage R, Lambert G, Faure MO, Serle J, Wang RF, Garrigue JS.

J Ocul Pharmacol Ther. 2012 Oct;28(5):515-23. Epub 2012 Jun 6.

PMID:
22671995
17.

A phase 2, randomized, dose-response trial of taprenepag isopropyl (PF-04217329) versus latanoprost 0.005% in open-angle glaucoma and ocular hypertension.

Schachar RA, Raber S, Courtney R, Zhang M.

Curr Eye Res. 2011 Sep;36(9):809-17. doi: 10.3109/02713683.2011.593725.

PMID:
21851167
19.

Effects of travoprost eye drops on intraocular pressure and pulsatile ocular blood flow: a 180-day, randomized, double-masked comparison with latanoprost eye drops in patients with open-angle glaucoma.

Cardascia N, Vetrugno M, Trabucco T, Cantatore F, Sborgia C.

Curr Ther Res Clin Exp. 2003 Jul;64(7):389-400. doi: 10.1016/S0011-393X(03)00112-7.

20.

Pneumatic trabeculoplasty vs latanoprost as adjunctive therapy to timolol in primary open-angle glaucoma or ocular hypertension.

Uva MG, Longo A, Reibaldi M.

Graefes Arch Clin Exp Ophthalmol. 2009 Aug;247(8):1103-9. doi: 10.1007/s00417-009-1055-0. Epub 2009 Feb 27.

PMID:
19247684

Supplemental Content

Support Center